We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Mitral Regurgitation
MedXY News
EnglishTag

Mitral Regurgitation

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation
CardiologyMitral RegurgitationMultivalve Disease

Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation

By MedXY|Sep 11, 2026

This propensity-matched study shows that in patients undergoing tricuspid TEER for severe TR, untreated moderate MR is linked to worse survival, while combined mitral and tricuspid TEER improves mortality and functional outcomes, highlighti

Long-Term Survival Outcomes in Asymptomatic Patients with Degenerative Mitral Regurgitation: Insights from a 25-Year Prospective Cohort Study
Cardiology
Mitral Regurgitation
effective regurgitant orifice

Long-Term Survival Outcomes in Asymptomatic Patients with Degenerative Mitral Regurgitation: Insights from a 25-Year Prospective Cohort Study

By MedXY|Aug 4, 2026

This 25-year prospective study evaluates the prognostic value of quantified mitral regurgitation (MR) severity and shows that early surgical intervention in upper-moderate MR improves long-term survival in asymptomatic patients.

TEER vs. Medical Therapy: Redefining the Management of Atrial Functional Mitral Regurgitation
CardiologyAFMRheart failure

TEER vs. Medical Therapy: Redefining the Management of Atrial Functional Mitral Regurgitation

By MedXY|Mar 27, 2026

A large-scale registry analysis demonstrates that Transcatheter Edge-to-Edge Repair (TEER) significantly reduces mortality and heart failure hospitalizations in patients with atrial functional mitral regurgitation (AFMR) compared to medical

Navigating the AfMR Maze: Expert Consensus and the Future of Mitral Regurgitation Diagnosis
CardiologyCardiologyESC Guidelines

Navigating the AfMR Maze: Expert Consensus and the Future of Mitral Regurgitation Diagnosis

By MedXY|Mar 25, 2026

This article examines the debate between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting why the JACC Expert Consensus offers a more robust framework for clinical prognosis and patient classification

Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines
CardiologyCardiologyESC Guidelines

Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines

By MedXY|Mar 21, 2026

This article explores the critical differences between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting how the JACC Consensus provides a more robust prognostic framework for managing this emerging he

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Lessons from the REVEAL-HCM Study
Cardiologyheart failureHypertrophic Cardiomyopathy

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Lessons from the REVEAL-HCM Study

By MedXY|Mar 20, 2026

The REVEAL-HCM study demonstrates that the prognostic impact of mitral regurgitation varies significantly across HCM subtypes, with notable risk in nonobstructive and apical forms, but not in obstructive or end-stage HCM.

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Prognostic Impact Varies Significantly by Subtype
CardiologyCardiologyheart failure

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Prognostic Impact Varies Significantly by Subtype

By MedXY|Mar 3, 2026

The REVEAL-HCM study demonstrates that while mitral regurgitation is a frequent comorbidity in hypertrophic cardiomyopathy, its prognostic impact is highly subtype-specific, significantly affecting outcomes in non-obstructive subtypes but s

M-TEER Benefits in Secondary Mitral Regurgitation: Consistent Clinical and Quality-of-Life Improvements Regardless of Baseline Health Status
Cardiologyheart failureMitral Regurgitation

M-TEER Benefits in Secondary Mitral Regurgitation: Consistent Clinical and Quality-of-Life Improvements Regardless of Baseline Health Status

By MedXY|Jan 3, 2026

The RESHAPE-HF2 trial reveals that mitral transcatheter edge-to-edge repair (M-TEER) significantly reduces cardiovascular risks and enhances health status across all baseline patient conditions, reinforcing its role as a key intervention fo

AI-Enhanced ECG Predicts Future Regurgitant Valvular Disease: Large International Study Shows Promise for Earlier Detection and Targeted Echocardiography
AIAI-ECGMitral Regurgitation

AI-Enhanced ECG Predicts Future Regurgitant Valvular Disease: Large International Study Shows Promise for Earlier Detection and Targeted Echocardiography

By MedXY|Dec 1, 2025

An international study developed AI-ECG models that diagnose and predict future moderate–severe mitral, tricuspid, and aortic regurgitation, validated across distinct populations and linked to subclinical chamber remodelling.

Transseptal TMVR with the SAPIEN M3 Lowers 1‑Year Mortality/HF Rehospitalisation in Patients Unsuitable for Surgery or TEER
CardiologyMitral Regurgitation

Transseptal TMVR with the SAPIEN M3 Lowers 1‑Year Mortality/HF Rehospitalisation in Patients Unsuitable for Surgery or TEER

By MedXY|Nov 10, 2025

A multicountry, single‑arm pivotal trial of the SAPIEN M3 transseptal transcatheter mitral valve replacement (TMVR) in patients deemed unsuitable for surgery or TEER demonstrated a 1‑year composite rate of death or heart‑failure rehospitali

Real-World Insights into Clinical Presentation and Outcomes After Mitral Valve Surgery from the MITRACURE Registry
Cardiologyclinical outcomesMitral Regurgitation

Real-World Insights into Clinical Presentation and Outcomes After Mitral Valve Surgery from the MITRACURE Registry

By MedXY|Oct 6, 2025

The MITRACURE registry reveals late-stage referral and suboptimal early intervention in mitral regurgitation surgery, highlighting the need for improved management strategies to enhance repair rates and reduce mortality.

Real-World Insights into Clinical Presentation and Surgical Outcomes of Mitral Regurgitation from the MITRACURE Registry
Cardiologyclinical outcomesMitral Regurgitation

Real-World Insights into Clinical Presentation and Surgical Outcomes of Mitral Regurgitation from the MITRACURE Registry

By MedXY|Oct 6, 2025

The MITRACURE international registry reveals that mitral valve surgery patients often present late in disease progression with advanced symptoms, showing modest repair rates and notable in-hospital mortality, underscoring the need for earli

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities